Yüklüyor......
CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?
INTRODUCTION: The outcome for patients with glioblastoma (GBM) remains poor, and there is an urgent need to develop novel therapeutic approaches. T cells genetically modified with chimeric antigen receptor (CARs) hold the promise to improve outcomes since they recognize and kill cells through differ...
Kaydedildi:
| Yayımlandı: | Expert Rev Anticancer Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6191291/ https://ncbi.nlm.nih.gov/pubmed/29533108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2018.1451749 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|